Comparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of HER2 Positive BC
Clinical trial NCT05918328 · RECRUITING
Trial details
- NCT number
- NCT05918328
- Sponsor
- Henan Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-03
- Primary completion
- 2025-12-01
- Enrollment
- 610
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.